TJ Biopharma
Latest round
- Series C
Last raised
- Sep 2025
Total raised
- $154M
Investors
- 14
About TJ Biopharma
Founded in 2019 and based in Hangzhou, China, TJ Biopharma is a pharmaceutical company that focuses on biomedical research and development. TJ Biopharma operates R&D bases in Shanghai and Beijing and manufacturing facilities in Hangzhou. In 2022, it achieved GMP production., Ltd. which was initially a part of the business operations in Greater China of the US-based and Nasdaq-listed pharmaceutical company I-Mab Group., a company located in Shanghai) to the Hangzhou company., Ltd., Ltd. respectively, with the latter being a wholly-owned subsidiary of the former (collectively known as TJ Biopharma). TJ Biopharma is committed to the research and development, production, certification, and product sales of biopharmaceuticals. The product lines cover diabetes, tumors, autoimmune diseases, and other fields. The company generates revenue from developing biotechnology and biopharmaceutical products.
Who invested in TJ Biopharma
14 investors across 2 rounds
See all investors in TJ Biopharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about TJ Biopharma
Who invested in TJ Biopharma?
TJ Biopharma has 14 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has TJ Biopharma raised?
TJ Biopharma has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did TJ Biopharma last raise money?
TJ Biopharma's most recent round on record is a Series C, in Sep 2025.
What does TJ Biopharma do?
Founded in 2019 and based in Hangzhou, China, TJ Biopharma is a pharmaceutical company that focuses on biomedical research and development.
Where is TJ Biopharma headquartered?
TJ Biopharma is headquartered in Hangzhou, China.
Which VCs invest in companies like TJ Biopharma?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at TJ Biopharma's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like TJ Biopharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.